Found 5 matching trials
Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715
PHASE110 healthy volunteers will be enrolled to each receive two subcutaneous inj...
Location
Therapeutics Clinical Research
Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea
PHASE2The aim of this study is to evaluate the safety, tolerability, and pharmaco...
Location
Soroka Medical Center
Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics
PHASE2The aim of this study is to examine the effects of ISIS 113715 monotherapy ...
Location
Yale - New Haven Hospital
Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment
PHASE2The aim of this study is to evaluate the safety, tolerability, and pharmaco...
Location
NZOZ Specjalistyczny Osrodek Internistyczno Diabetologiczny
Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea
PHASE2The purpose of this study is to provide an initial assessment of the safety...
Location
Niepubliczny Zakład Opieki Zdrowotnej Specjalistyczny Ośrodek Internistyczno